Editorial introductions
Brush cells, the newly identified gatekeepers of the urinary tract
Clinical implications of the microbiome in urinary tract diseases
The role of prostatic inflammation in the development and progression of benign and malignant diseases
Asymptomatic bacteriuria, to screen or not to screen – and when to treat?
Tailored perioperative antimicrobial prophylaxis in urological surgery
The role of nonantibiotic treatment of community-acquired urinary tract infections
The revival of old antibiotics for treatment of uncomplicated urinary tract infections in the era of antibiotic stewardship
An update on classification and management of urosepsis
High-intensity focused ultrasound for focal therapy
Can we improve transurethral resection of the bladder tumour for nonmuscle invasive bladder cancer?
Partial gland ablation in the management of prostate cancer
Miniaturization of percutaneous nephrolithotomy Smaller, but better?
New technologies for upper tract urothelial carcinoma management
Single use and disposable flexible ureteroscopes
Transurethral en bloc resection of nonmuscle invasive bladder cancer